Enhancement of Methyldopa Metabolism with Barbiturate
- 28 August 1971
- Vol. 3 (5773) , 518-519
- https://doi.org/10.1136/bmj.3.5773.518
Abstract
The spurious increase in serum catecholamine levels associated with methyldopa treatment can be reduced by the simultaneous administration of phenobarbitone. This accelerating effect of phenobarbitone on methyldopa metabolism has been demonstrated in relation to both adrenaline and noradrenaline, and investigations suggest that it is due to the effect of barbiturate on the activity of metabolizing enzymes.Keywords
This publication has 6 references indexed in Scilit:
- PHARMACOLOGICAL IMPLICATIONS OF MICROSOMAL ENZYME INDUCTION1967
- Drug interactions in manClinical Pharmacology & Therapeutics, 1965
- METABOLISM OF METHYLDOPA IN HYPERTENSIVE HUMAN SUBJECTS1964
- Spurious Elevation of Urinary Catecholamines During Therapy with Alpha-Methyl-DopaJAMA, 1962
- THIRTY-MINUTE SCREENING TEST FOR PHÆOCHROMOCYTOMAThe Lancet, 1957
- Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanineArchives of Biochemistry and Biophysics, 1954